1. Home
  2. EZPW vs SYRE Comparison

EZPW vs SYRE Comparison

Compare EZPW & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • SYRE
  • Stock Information
  • Founded
  • EZPW 1989
  • SYRE 2013
  • Country
  • EZPW United States
  • SYRE United States
  • Employees
  • EZPW N/A
  • SYRE N/A
  • Industry
  • EZPW Other Specialty Stores
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZPW Consumer Discretionary
  • SYRE Health Care
  • Exchange
  • EZPW Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • EZPW 860.3M
  • SYRE 841.4M
  • IPO Year
  • EZPW 1991
  • SYRE 2016
  • Fundamental
  • Price
  • EZPW $13.96
  • SYRE $15.18
  • Analyst Decision
  • EZPW Strong Buy
  • SYRE Buy
  • Analyst Count
  • EZPW 3
  • SYRE 8
  • Target Price
  • EZPW $17.83
  • SYRE $50.00
  • AVG Volume (30 Days)
  • EZPW 2.1M
  • SYRE 595.7K
  • Earning Date
  • EZPW 04-28-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • EZPW N/A
  • SYRE N/A
  • EPS Growth
  • EZPW 18.94
  • SYRE N/A
  • EPS
  • EZPW 1.19
  • SYRE N/A
  • Revenue
  • EZPW $1,202,458,000.00
  • SYRE N/A
  • Revenue This Year
  • EZPW $9.68
  • SYRE N/A
  • Revenue Next Year
  • EZPW $6.36
  • SYRE N/A
  • P/E Ratio
  • EZPW $11.53
  • SYRE N/A
  • Revenue Growth
  • EZPW 8.14
  • SYRE N/A
  • 52 Week Low
  • EZPW $9.65
  • SYRE $10.91
  • 52 Week High
  • EZPW $16.60
  • SYRE $40.49
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 35.02
  • SYRE 54.31
  • Support Level
  • EZPW $13.58
  • SYRE $14.12
  • Resistance Level
  • EZPW $15.05
  • SYRE $14.99
  • Average True Range (ATR)
  • EZPW 0.49
  • SYRE 1.04
  • MACD
  • EZPW -0.24
  • SYRE 0.25
  • Stochastic Oscillator
  • EZPW 13.10
  • SYRE 83.07

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: